Applying population mechanistic modelling to find determinants of CAR-T dynamics in month-one lymphoma patients
Chimeric Antigen Receptor (CAR) T-cells have been utilised for the treatment of several malignancies, including Non-Hodgkin Lymphomas (NHL). A myriad of product- and patient-specific factors determine the extent of patient response, and determining which are most impactful requires analysis of clini...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2024
|